Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular heterogeneity of B-lineage diffuse large cell lymphoma.
Volpe G, Vitolo U, Carbone A, Pastore C, Bertini M, Botto B, Audisio E, Freilone R, Novero D, Cappia S, De Giuli P, Mazza U, Resegotti L, Palestro G, Saglio G, Gaidano G. Volpe G, et al. Among authors: audisio e. Genes Chromosomes Cancer. 1996 May;16(1):21-30. doi: 10.1002/(SICI)1098-2264(199605)16:1<21::AID-GCC3>3.0.CO;2-5. Genes Chromosomes Cancer. 1996. PMID: 9162193
Combined modality treatment with a weekly brief chemotherapy (ACOP-B) followed by locoregional radiotherapy in localized-stage intermediate- to high-grade non-Hodgkin's lymphoma.
Freilone R, Botto B, Vitolo U, Bertini M, Audisio E, Calvi R, Cucchi M, De Crescenzo A, Gallamini A, Ghio R, Griso L, Levis A, Massara G, Orsucci L, Ricardi U, Rota Scalabrini D, Salvi F, Secondo V, Resegotti L. Freilone R, et al. Among authors: audisio e. Ann Oncol. 1996 Nov;7(9):919-24. doi: 10.1093/oxfordjournals.annonc.a010794. Ann Oncol. 1996. PMID: 9006742 Free article. Clinical Trial.
Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients.
Vitolo U, Gaidano G, Botto B, Volpe G, Audisio E, Bertini M, Calvi R, Freilone R, Novero D, Orsucci L, Pastore C, Capello D, Parvis G, Sacco C, Zagonel V, Carbone A, Mazza U, Palestro G, Saglio G, Resegotti L. Vitolo U, et al. Among authors: audisio e. Ann Oncol. 1998 Jan;9(1):55-61. doi: 10.1023/a:1008201729596. Ann Oncol. 1998. PMID: 9541684 Free article.
Detection of minimal residual disease in peripheral blood stem cells from two acute myeloid leukemia patients with trisomy 8 predicts early relapse after autologous bone marrow transplantation.
Scaravaglio P, Guglielmelli T, Giugliano E, Marmont F, Audisio E, Gallo E, Saglio G, Rege-Cambrin G. Scaravaglio P, et al. Among authors: audisio e. Cancer Genet Cytogenet. 2002 Feb;133(1):98-101. doi: 10.1016/s0165-4608(01)00564-7. Cancer Genet Cytogenet. 2002. PMID: 11890999
Atypical Differentiation Syndrome with Sudden Vision Loss in Acute Promyelocytic Leukemia Treated with ATRA plus ATO: a Clinical Case.
Boscaro E, Cerrano M, Tibaldi T, Zavatto C, Reibaldi M, Freilone R, Urbino I, Audisio E, Cattani I. Boscaro E, et al. Among authors: audisio e. Mediterr J Hematol Infect Dis. 2024 Jul 1;16(1):e2024063. doi: 10.4084/MJHID.2024.063. eCollection 2024. Mediterr J Hematol Infect Dis. 2024. PMID: 38984094 Free PMC article. No abstract available.
Core binding factor acute myeloid leukaemia and c-KIT mutations.
Riera L, Marmont F, Toppino D, Frairia C, Sismondi F, Audisio E, Di Bello C, D'Ardia S, Di Celle PF, Messa E, Inghirami G, Vitolo U, Pich A. Riera L, et al. Among authors: audisio e. Oncol Rep. 2013 May;29(5):1867-72. doi: 10.3892/or.2013.2328. Epub 2013 Mar 5. Oncol Rep. 2013. PMID: 23467883 Free article.
Evolving Therapeutic Approaches for Older Patients with Acute Myeloid Leukemia in 2021.
Urbino I, Secreto C, Olivi M, Apolito V, D'Ardia S, Frairia C, Giai V, Aydin S, Freilone R, Dellacasa C, Giaccone L, Ferrero D, Audisio E, Busca A, Cerrano M. Urbino I, et al. Among authors: audisio e. Cancers (Basel). 2021 Oct 11;13(20):5075. doi: 10.3390/cancers13205075. Cancers (Basel). 2021. PMID: 34680226 Free PMC article. Review.
Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges.
Olivi M, Di Biase F, Lanzarone G, Arrigo G, Martella F, Apolito V, Secreto C, Freilone R, Bruno B, Audisio E, Ferrero D, Beggiato E, Cerrano M. Olivi M, et al. Among authors: audisio e. Curr Treat Options Oncol. 2023 Jun;24(6):693-710. doi: 10.1007/s11864-023-01089-w. Epub 2023 Apr 26. Curr Treat Options Oncol. 2023. PMID: 37099265 Review.
76 results